112 related articles for article (PubMed ID: 1372785)
21. Blockade of bepridil on IA and IK in acutely isolated hippocampal CA1 neurons.
Hu H; Yang D; Lin Z; Wu C; Zhou P; Dai D
Brain Res; 1998 Nov; 809(2):149-54. PubMed ID: 9853105
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of cardiodepressive action among calcium antagonists from different classes: evidence for a mechanism at the single calcium channel level.
Braun S; Frey N; Herzig S; Hilbert C
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):586-93. PubMed ID: 1326719
[TBL] [Abstract][Full Text] [Related]
23. Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium.
Hashimoto H; Satoh N; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):683-90. PubMed ID: 2096300
[TBL] [Abstract][Full Text] [Related]
24. Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.
Massingham R; Van Zwieten PA
Cardiovasc Drugs Ther; 1989 Oct; 3(5):731-42. PubMed ID: 2488109
[TBL] [Abstract][Full Text] [Related]
25. Bepridil therapy: guidelines for patient selection and monitoring of therapy.
Singh BN
Am J Cardiol; 1992 Apr; 69(11):79D-85D. PubMed ID: 1553895
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of the bepridil-induced vasodilation of the rabbit mesenteric artery.
Suzuki H; Itoh T; Kuriyama H
J Pharmacol Exp Ther; 1985 Dec; 235(3):749-56. PubMed ID: 3878404
[TBL] [Abstract][Full Text] [Related]
27. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
[TBL] [Abstract][Full Text] [Related]
28. Electromechanical effects of bepridil on rabbit isolated hearts.
Anno T; Furuta T; Itoh M; Kodama I; Toyama J; Yamada K
Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
Zakhari S
Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of inhibition of the sodium current by bepridil in guinea-pig isolated ventricular cells.
Nawada T; Tanaka Y; Hisatome I; Sasaki N; Ohtahara A; Kotake H; Mashiba H; Sato R
Br J Pharmacol; 1995 Sep; 116(2):1775-80. PubMed ID: 8528559
[TBL] [Abstract][Full Text] [Related]
31. Effects of bepridil on stretch-activated BKca channels and stretch-induced extrasystoles in isolated chick hearts.
Jin H; Iribe G; Naruse K
Physiol Res; 2017 Jul; 66(3):459-465. PubMed ID: 28248537
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.
Garcia ML; Slaughter RS; King VF; Kaczorowski GJ
Biochemistry; 1988 Apr; 27(7):2410-5. PubMed ID: 3260109
[TBL] [Abstract][Full Text] [Related]
33. Second-generation calcium antagonists: search for greater selectivity and versatility.
Singh BN; Baky S; Nademanee K
Am J Cardiol; 1985 Jan; 55(3):214B-221B. PubMed ID: 3155893
[TBL] [Abstract][Full Text] [Related]
34. The role of the Ca(2+) regulatory sites of skeletal troponin C in modulating muscle fibre reactivity to the Ca(2+) sensitizer bepridil.
Kischel P; Bastide B; Potter JD; Mounier Y
Br J Pharmacol; 2000 Dec; 131(7):1496-502. PubMed ID: 11090126
[TBL] [Abstract][Full Text] [Related]
35. Bepridil opens the regulatory N-terminal lobe of cardiac troponin C.
Li Y; Love ML; Putkey JA; Cohen C
Proc Natl Acad Sci U S A; 2000 May; 97(10):5140-5. PubMed ID: 10792039
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens.
Chang GJ; Wu MH; Wu YC; Su MJ
Br J Pharmacol; 1996 Aug; 118(7):1571-83. PubMed ID: 8842417
[TBL] [Abstract][Full Text] [Related]
37. Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle.
Kitazawa T; Hamada E; Kitazawa K; Gaznabi AK
J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):497-511. PubMed ID: 9080377
[TBL] [Abstract][Full Text] [Related]
38. Overview of the clinical pharmacology of antiarrhythmic drugs.
Woosley RL; Funck-Brentano C
Am J Cardiol; 1988 Jan; 61(2):61A-69A. PubMed ID: 2447771
[TBL] [Abstract][Full Text] [Related]
39. Bepridil: a new long-acting calcium channel blocking agent.
Zeller FP; Spinler SA
Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
[TBL] [Abstract][Full Text] [Related]
40. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
Hasegawa GR
Clin Pharm; 1988 Feb; 7(2):97-108. PubMed ID: 3280222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
